Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: a pilot study

The low dose application of chemotherapeutic agents such as paclitaxel was previously shown to initiate anti-tumor activity by neutralizing myeloid-derived suppressor cells (MDSCs) in melanoma mouse models. Here, we investigated immunomodulating effects of low-dose paclitaxel in 9 metastatic melanom...

Full description

Saved in:
Bibliographic Details
Main Authors: Gebhardt, Christoffer (Author) , Simon, Sonja C. S. (Author) , Bitsch, Rebekka (Author) , Gries, Mirko (Author) , Mun, Dong Hun (Author) , Reinhard, Raphael (Author) , Holland-Letz, Tim (Author) , Umansky, Viktor (Author) , Utikal, Jochen (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Cellular immunology
Year: 2021, Volume: 360, Pages: 1-9
ISSN:1090-2163
DOI:10.1016/j.cellimm.2020.104274
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cellimm.2020.104274
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0008874920304342
Get full text
Author Notes:Christoffer Gebhardt, Sonja C.S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal

MARC

LEADER 00000caa a2200000 c 4500
001 1751134792
003 DE-627
005 20230427005710.0
007 cr uuu---uuuuu
008 210311s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.cellimm.2020.104274  |2 doi 
035 |a (DE-627)1751134792 
035 |a (DE-599)KXP1751134792 
035 |a (OCoLC)1341398454 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gebhardt, Christoffer  |d 1976-  |e VerfasserIn  |0 (DE-588)13051151X  |0 (DE-627)503031666  |0 (DE-576)298240289  |4 aut 
245 1 0 |a Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade  |b a pilot study  |c Christoffer Gebhardt, Sonja C.S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal 
264 1 |c 2021 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 28 December 2020 
500 |a Gesehen am 30.11.2021 
520 |a The low dose application of chemotherapeutic agents such as paclitaxel was previously shown to initiate anti-tumor activity by neutralizing myeloid-derived suppressor cells (MDSCs) in melanoma mouse models. Here, we investigated immunomodulating effects of low-dose paclitaxel in 9 metastatic melanoma patients resistant to prior treatments. Three patients showed response to therapy (two partial responses and one stable disease). In responding patients, paclitaxel decreased the frequency and immunosuppressive pattern of MDSCs in the peripheral blood and skin metastases. Furthermore, paclitaxel modulated levels of inflammatory mediators in the serum. In addition, responders displayed enhanced frequencies of tumor-infiltrating CD8+ T cells and their activity indicated by the upregulation of CD25 and TCR ζ-chain expression. Our study suggests that low-dose paclitaxel treatment could improve clinical outcome of some advanced melanoma patients by enhancing anti-tumor immunity and might be proposed for combined melanoma immunotherapy. 
650 4 |a Immune checkpoint blockade 
650 4 |a Immunotherapy 
650 4 |a Melanoma 
650 4 |a Myeloid suppressor cells 
650 4 |a Paclitaxel 
700 1 |a Simon, Sonja C. S.  |d 1990-  |e VerfasserIn  |0 (DE-588)1208016903  |0 (DE-627)1694314316  |4 aut 
700 1 |a Bitsch, Rebekka  |d 1991-  |e VerfasserIn  |0 (DE-588)1163544582  |0 (DE-627)1027872069  |0 (DE-576)508043565  |4 aut 
700 1 |a Gries, Mirko  |d 1985-  |e VerfasserIn  |0 (DE-588)1229655727  |0 (DE-627)1751726452  |4 aut 
700 1 |a Mun, Dong Hun  |e VerfasserIn  |4 aut 
700 1 |a Reinhard, Raphael  |d 1988-  |e VerfasserIn  |0 (DE-588)112275499X  |0 (DE-627)87613326X  |0 (DE-576)481470344  |4 aut 
700 1 |a Holland-Letz, Tim  |e VerfasserIn  |0 (DE-588)142336491  |0 (DE-627)658880470  |0 (DE-576)343311291  |4 aut 
700 1 |a Umansky, Viktor  |d 1955-  |e VerfasserIn  |0 (DE-588)102885756X  |0 (DE-627)731733207  |0 (DE-576)376300078  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
773 0 8 |i Enthalten in  |t Cellular immunology  |d Orlando, Fla. : Academic Press, 1970  |g 360(2021), Artikel-ID 104274, Seite 1-9  |h Online-Ressource  |w (DE-627)254635059  |w (DE-600)1462601-9  |w (DE-576)104193646  |x 1090-2163  |7 nnas  |a Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade a pilot study 
773 1 8 |g volume:360  |g year:2021  |g elocationid:104274  |g pages:1-9  |g extent:9  |a Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade a pilot study 
856 4 0 |u https://doi.org/10.1016/j.cellimm.2020.104274  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0008874920304342  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210311 
993 |a Article 
994 |a 2021 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 9  |y j 
998 |g 102885756X  |a Umansky, Viktor  |m 102885756X:Umansky, Viktor  |d 140000  |d 60000  |d 61900  |e 140000PU102885756X  |e 60000PU102885756X  |e 61900PU102885756X  |k 0/140000/  |k 0/60000/  |k 1/60000/61900/  |p 8 
998 |g 142336491  |a Holland-Letz, Tim  |m 142336491:Holland-Letz, Tim  |d 50000  |e 50000PH142336491  |k 0/50000/  |p 7 
998 |g 112275499X  |a Reinhard, Raphael  |m 112275499X:Reinhard, Raphael  |d 60000  |d 61900  |e 60000PR112275499X  |e 61900PR112275499X  |k 0/60000/  |k 1/60000/61900/  |p 6 
998 |g 1229655727  |a Gries, Mirko  |m 1229655727:Gries, Mirko  |d 60000  |e 60000PG1229655727  |k 0/60000/  |p 4 
998 |g 1163544582  |a Bitsch, Rebekka  |m 1163544582:Bitsch, Rebekka  |d 60000  |d 61900  |e 60000PB1163544582  |e 61900PB1163544582  |k 0/60000/  |k 1/60000/61900/  |p 3 
998 |g 1208016903  |a Simon, Sonja C. S.  |m 1208016903:Simon, Sonja C. S.  |d 60000  |d 61900  |e 60000PS1208016903  |e 61900PS1208016903  |k 0/60000/  |k 1/60000/61900/  |p 2 
998 |g 13051151X  |a Gebhardt, Christoffer  |m 13051151X:Gebhardt, Christoffer  |p 1  |x j 
999 |a KXP-PPN1751134792  |e 3884782991 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Available online 28 December 2020","Gesehen am 30.11.2021"],"id":{"doi":["10.1016/j.cellimm.2020.104274"],"eki":["1751134792"]},"title":[{"subtitle":"a pilot study","title":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade","title_sort":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade"}],"recId":"1751134792","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"relHost":[{"recId":"254635059","pubHistory":["1.1970 -"],"origin":[{"publisher":"Academic Press ; Elsevier","dateIssuedKey":"1970","publisherPlace":"Orlando, Fla. ; Amsterdam [u.a.]","dateIssuedDisp":"1970-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"9","year":"2021","pages":"1-9","text":"360(2021), Artikel-ID 104274, Seite 1-9","volume":"360"},"note":["Gesehen am 22.01.2020"],"disp":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade a pilot studyCellular immunology","title":[{"title":"Cellular immunology","title_sort":"Cellular immunology"}],"id":{"issn":["1090-2163"],"eki":["254635059"],"zdb":["1462601-9"]}}],"person":[{"roleDisplay":"VerfasserIn","family":"Gebhardt","role":"aut","display":"Gebhardt, Christoffer","given":"Christoffer"},{"family":"Simon","roleDisplay":"VerfasserIn","given":"Sonja C. S.","role":"aut","display":"Simon, Sonja C. S."},{"given":"Rebekka","role":"aut","display":"Bitsch, Rebekka","family":"Bitsch","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Gries","display":"Gries, Mirko","role":"aut","given":"Mirko"},{"role":"aut","display":"Mun, Dong Hun","given":"Dong Hun","roleDisplay":"VerfasserIn","family":"Mun"},{"roleDisplay":"VerfasserIn","family":"Reinhard","role":"aut","display":"Reinhard, Raphael","given":"Raphael"},{"role":"aut","display":"Holland-Letz, Tim","given":"Tim","family":"Holland-Letz","roleDisplay":"VerfasserIn"},{"family":"Umansky","roleDisplay":"VerfasserIn","role":"aut","display":"Umansky, Viktor","given":"Viktor"},{"display":"Utikal, Jochen","role":"aut","given":"Jochen","roleDisplay":"VerfasserIn","family":"Utikal"}],"name":{"displayForm":["Christoffer Gebhardt, Sonja C.S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal"]},"physDesc":[{"extent":"9 S."}]} 
SRT |a GEBHARDTCHPOTENTIALT2021